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Available online 8 September 2016Over the last decade, the ﬁeld of imaging genomics has combined high-throughput genotype data with quantita-
tive magnetic resonance imaging (QMRI) measures to identify genes associated with brain structure, cognition,
and several brain-related disorders. Despite its successful application in different psychiatric and neurological
disorders, the ﬁeld has yet to be advanced in epilepsy. In this article we examine the relevance of imaging geno-
mics for future genetic studies in epilepsy from three perspectives. First, we discuss prior genome-wide genetic
mapping efforts in epilepsy, considering the possibility that some studiesmay have been constrained by inherent
theoretical and methodological limitations of the genome-wide association study (GWAS) method. Second, we
offer a brief overview of the imaging genomics paradigm, from its original inception, to its role in the discovery
of important risk genes in a number of brain-related disorders, and its successful application in large-scale mul-
tinational research networks. Third, we provide a comprehensive review of past studies that have explored the
eligibility of brain QMRI traits as endophenotypes for epilepsy. While the breadth of studies exploring QMRI-
derived endophenotypes in epilepsy remains narrow, robust syndrome-speciﬁc neuroanatomical QMRI traits
have the potential to serve as accessible and relevant intermediate phenotypes for future geneticmapping efforts
in epilepsy.
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Epilepsy is the most common serious neurological disorder. It com-
prises a heterogeneous group of epilepsy syndromes characterized byy and Neurosurgery, Montreal
Street, Montreal, Quebec H3A
saini).
. This is an open access article undera shared predisposition to develop unprovoked epileptic seizures
(Fisher et al., 2014). Based on the origin of seizure activity, epileptic sei-
zures and syndromes can be focal or generalized (Berg et al., 2010). The
underlying cause varies greatly across different epilepsy syndromes. Es-
timates from twin studies indicate a signiﬁcant genetic role in most ep-
ilepsy syndromes (Miller et al., 1998; Kjeldsen et al., 2001). Newly
developed techniques to estimate heritability from dense genotype
data have indicated that at least 26% of the phenotypic variation in epi-
lepsy is collectively explained by genetic variants occurring commonlythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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heritability, most epilepsy-causing genetic mutations have been identi-
ﬁed by linkage analyses in families with Mendelian patterns of inheri-
tance, which account for b1% of all epilepsy syndromes. Common
epilepsies often exhibit a complex or obscure inheritance pattern: cau-
sation may be attributable to multiple genetic variants interacting
with each other and with environmental factors. Although steady prog-
ress is being made, the genetic determinants underlying most common
epilepsy syndromes remain largely unknown.
2. Genetic studies of complex epilepsies - current constraints and
limitations
Several single-gene mutations have been linked to familial forms of
epilepsy (Hardies et al., 2016). For example, familial forms of genetic
generalized epilepsies (GGEs) have been linked to mutations in the
SLC2A1 gene that encodes GLUT1, a cell membrane glucose transporter
(Striano et al., 2012). Mutations in LGI1 have been associated with fa-
milial focal epilepsies, including autosomal-dominant lateral temporal
lobe epilepsy (ADLTLE) (Kalachikov et al., 2002). Interestingly, pleiotro-
py is not uncommon: a number of geneswhichwhenmutated can cause
epilepsy are associated with diverse epilepsy phenotypes. For example,
mutations in the genes SCN1A, SCN2A, SCN1B, KCNQ2, DEPDC5 and
TBC1D24 can all cause a variety of epilepsies (Gambardella and Marini,
2009; Dibbens et al., 2013; Allen et al., 2014; Balestrini et al., 2016).
The genetic determinants of common epilepsy syndromes, where
family history is lacking or suggests a complex inheritance pattern, are
much less clearly deﬁned. Their genetic architecture has been explored
in many candidate gene studies, deep sequencing analyses and
genome-wide association studies (GWASs; Helbig et al., 2008; Leu
et al., 2016). Rare sequence and copy number variants of large effect
have been identiﬁed in childhood absence epilepsies (Chen et al.,
2003), GGEs (Helbig et al., 2009) and other epilepsy phenotypes
(Heinzen et al., 2010; Klassen et al., 2011). GWAS has shown that com-
mon polymorphisms have a role in complex focal epilepsies with
known or suspected brain lesions (Guo et al., 2012), mesial temporal
lobe epilepsy (MTLE) with hippocampal sclerosis (Kasperaviciute
et al., 2013) and complex generalized epilepsies (EPICURE Consortium
et al., 2012). A recentmeta-analysis of genome-wide data from8696ep-
ilepsy cases and 26,157 controls revealed two susceptibility genes,
SCN1A and PCDH7, as risk loci across all forms of epilepsy, and a third
risk locus (at VRK2 or FANCL) for generalized forms of the disorder
(ILAE Consortium on Complex Epilepsies, 2014). Despite these promis-
ingﬁndings, the replication rate and functional validation of susceptibil-
ity loci for complex epilepsies is poor (Leu et al., 2016).
Sample sizes need to be large for successful GWAS. Recent multisite
collaborations, such as those led by the International League Against Ep-
ilepsy (ILAE) Consortium on Complex Epilepsies (http://www.ilae.org/
Commission/class/consortium.cfm), address this by assembling larger
cohorts of epilepsy cases and healthy controls, boosting statistical
power. Even so, these genome-wide meta-analyses can aggregate data
fromdiverse ethnic groups and samples can be clinically heterogeneous.
Heterogeneity can make GWAS results harder to interpret, as the de-
tected genome-wide signalsmay bedriven by differences in linkage dis-
equilibrium (LD) structure between sub-cohorts, uncontrolled effects of
cryptic population stratiﬁcation (McClellan and King, 2010), synthetic
associations created by rare variants (Dickson et al., 2010; Wray et al.,
2011), or overrepresented effects from speciﬁc epilepsy subtypes or
sub-cohorts. Similarly, non-signiﬁcant ﬁndings may be attributed, in
part, to phenotype misclassiﬁcations (Manchia et al., 2013). GWAS
will also miss any consistent effects of rare genetic variants (Gershon
et al., 2011; Gibson, 2012).
GWASwas initiated based on a simple common disease-common var-
iant (CDCV) hypothesis, which posited that complex disorders, such as
epilepsy, are largely explained by amoderate number of variants occur-
ring commonly (N1%) in the general population (Botstein and Risch,2003; Pritchard and Cox, 2002; Reich and Lander, 2001). This perspec-
tive has since evolved into several diverging hypotheses. Some argue
that the genetic component of a disease is mainly due to a large number
of common variants of small effect (the inﬁnitesimalmodel). Others in-
sist that it is due to a large number of rare variants of large effect (the
rare allelemodel), and others still suggest a combination of genomic, en-
vironmental and epigenetic interactions (the broad sense heritability
model; see Gibson, 2012, for a review). Recent genome-wide meta-
analyses have integrated the broad-sense heritability hypothesis into
their statistical designs using linear mixed models (LMM), which restrict
heritability estimates to a certain class of single nucleotide polymor-
phisms (SNPs) in high LD with those on genotype platforms (Yang
et al., 2010, Zaitlen and Kraft, 2012). Despite these advances, the
number of novel genome-wide signiﬁcant ﬁndings remains sparse,
and the liability variance explained by each detected risk locus is low
(often b1%).
Typically, common susceptibility loci captured via case: control asso-
ciation studies exert subtle molecular and cellular alterations with re-
mote effects on gene transcription, protein structure, or protein
function (McCarthy and Hirschhorn, 2008). A complex clinical pheno-
type, such as seizure type or epilepsy syndrome, therefore tends to be
indirectly predicted by any associated genotype. Although large-scale
multisite meta-analyses may boost power to detect subtle biological ef-
fects, several creative alternatives may help to sidestep the complicated
phenotype integrity of common epilepsy syndromes (Pal and Strug,
2014). One widely investigated alternative is the use of intermediate
quantitative traits (QTs) that may be closer to the underlying biology
of the disease than the clinical phenotype. These intermediate QTs are
commonly referred to as endophenotypes.
3. Endophenotypes - deﬁnition and criteria
Endophenotypes are subclinical QTs, occupying the domain between
disease phenotype and the genetic variants that inﬂuence disease risk
(Gottesman and Gould, 2003). Unlike binary diagnostic outcomes (e.g.
‘patient’ versus ‘healthy control’), endophenotypes are quantiﬁable
measures that are arguably closer to the genetic architecture of a disease
than its clinical manifestation (e.g., seizure semiology) (Gould and
Gottesman, 2006). In theory, endophenotypes allow us to deconstruct
phenotypically heterogeneous syndromes, including epilepsy syn-
dromes, into phenomena more reﬂective of the underlying genetic ar-
chitecture, improving power to detect risk genes and their functional
consequences (Walters and Owen, 2007).
Several criteria have been proposed to identify valid endophenotypes,
since Gottesman & Shields' original (1973) conceptualization. Some cor-
ollaries and extensions continue to be discussed (see Miller and
Rockstroh, 2013, for a review), but the following ﬁve criteria are general-
ly accepted by the genetics community (Gould and Gottesman, 2006;
Hasler et al., 2006). An endophenotype should be:
1. Associated with illness in the relevant population
2. State independent (i.e., it manifests in an individual regardless of
whether an illness is active or not) and may require elicitation by a
challenge (e.g., glucose tolerance test in relatives of patients with
diabetes)
3. Heritable
4. Co-segregating with illness within families
5. Present in non-affected family members at a higher rate than in the
general population
In principle, endophenotypes may be biochemical, endocrinological,
electrophysiological, cognitive, or anatomical in nature (Gould and
Gottesman, 2006). A vast number of research tools have been applied
to characterize relevant endophenotypes in brain-related disorders;
ranging fromeyemovement recording (Mazhari et al., 2011), electroen-
cephalography (EEG) and magnetic resonance imaging (MRI; Iacono
and Malone, 2011), to behavioral measures and neuropsychological
528 S. Alhusaini et al. / NeuroImage: Clinical 12 (2016) 526–534batteries (Glahn et al., 2004; Mann et al., 2009). MRI is arguably one of
themost easily accessible andwidely employed of these techniques. In-
deed, in epilepsy, a large percentage of people with epilepsy undergo
brain MRI as part of their clinical evaluation to look for potential under-
lying structural abnormality (e.g. malformation of cortical development
or tumor). Quantitative MRI (QMRI) studies of people with epilepsy
have characterized a wide range of subtle structural and functional
brain alterations that are associated with particular epilepsy syndromes
(Mueller et al., 2009). Some proportion of these subtle brain alterations
may be due to early brain insults (e.g., central nervous system (CNS) in-
fection or head trauma), disease-related factors (e.g. recurrent seizure
activity or chronic medication use), or other environmental factors
(Lewis et al., 2014). However, genetic mechanisms may also play a
role, based on growing evidence from studies of asymptomatic ﬁrst-
degree relatives of epilepsy sufferers (Tsai et al., 2013).Fig. 1. Themaximumeffect sizes for the top individual common genetic variants (both for
discovery and replication samples) from genome-wide association studies of brain
structure (for example, hippocampal volume), schizophrenia (using traditional
case:control design), and other anthropomorphic traits including height and educational
attainment are shown (Franke et al., 2016). For quantitative traits, effect sizes were
measured in percent variance explained. For disease categories, effect sizes were
measured in percent variance explained on the liability scale. [Image is reproduced with
permission from nature publishing group (Nature Neuroscience, 2016)].4. QMRI traits as endophenotypes in genetic mapping studies: a
promising future?
For a number of psychiatric illnesses, there is an ongoing quest
to identify heritable, state-independent, neuroimaging-derived
endophenotypes (Meyer-Lindenberg, 2010). For example, schizophre-
nia patients and their asymptomatic ﬁrst-degree relatives appear to ex-
hibit a similar pattern of brain structural alterations, including reduced
prefrontal and temporal lobe grey matter (GM) volume (Cannon et al.,
2002), vertical displacement of the corpus callosum (Narr et al., 2002),
and inward deformity at the head of the hippocampus (Tepest et al.,
2003). Similarly, in bipolar disorder, signiﬁcant white matter (WM) al-
terations in the corpus callosum, posterior thalamic radiations and left
superior longitudinal fasciculus have been reported in patients and
their asymptomatic siblings (Sprooten et al., 2013). Also, in major de-
pressive disorder, GM alterations within the ventral diencephalon
have been associated, in part, with genetic risk factors (Glahn et al.,
2012). Despite limitations attributed to variable sensitivity of different
image analysis techniques and modest statistical power, several of
these ﬁndings have been validated using larger sample sizes and stan-
dardized image processing algorithms (de Zwarte et al., 2016;
Sprooten et al., 2016).
Many of the proposed neuroanatomical endophenotypes show
moderate-to-high heritability in healthy and affected populations
(Peper et al., 2007; Glahn et al., 2007; Goldman et al., 2008; den
Braber et al., 2013). This has led some groups to pioneer a new research
paradigm - known as imaging genomics - whereby neuroimaging-
derived endophenotypes are used as quantitative phenotypes for
genome-wide genetic mapping studies (Thompson et al., 2014).
Under this imaging genomics model, a brain measure (such as the vol-
ume of a region of interest) is speciﬁed as a QT across a moderate-to-
large sample of genome-wide genotyped participants. A regression
model is then applied to test for an association between the additive al-
lelic dosage of each SNP (independent variable) and the imaging pheno-
type of interest (dependent variable). Imaging genomics has
successfully mapped the effects on the brain of a number of important
genetic variants that are also associated with disease risk, sometimes
using smaller samples than those required by traditional case-control
association studies. In one of the ﬁrst GWAS to be conducted directly
on neuroimaging data, Potkin et al. (2009) analyzed genotypes and
QMRI phenotype data from 381 Alzheimer's disease (AD) patients, col-
lected as part of the Alzheimer's Disease Neuroimaging Initiative
(ADNI). Although such a sample would rate as very small for a GWAS
in general, the group still detected a signiﬁcant association between var-
iants in the TOMM40 and APOE genes and hippocampal volume (HV) in
AD (Potkin et al., 2009). Shortly after the ADNI dataset was released to
the public, over 100 discoveries were reported, relating differences in
brain images to common variants in the BIN1, CLU, CR1 and PICALM
genes - all of which were corroborated by imaging, cerebrospinal ﬂuid(CSF) markers and cognitive phenotypes (see Shen et al., 2014, for a
review).
In recent years, the ﬁeld of imaging genomics has expanded into a
number of multinational research networks. Some notable collabora-
tions include the Early Growth Genetics (EGG) project, which identiﬁed
a signiﬁcant association between variants in the HMGA2 gene and head
circumference at birth in a cohort of over 69,000 individuals (Horikoshi
et al., 2013); the Enhancing Neuro Imaging through Meta-Analysis
(ENIGMA) consortium (http://enigma.ini.usc.edu), which replicated
the association between HMGA2 and intracranial volume, in addition
to identifying a novel intergenic variant associated with HV in a sample
of almost 8000 adult participants (Stein et al., 2012); and the Cohorts of
Heart and Aging Research in Genomic Epidemiology (CHARGE) group,
which reported variants associated with HV reduction (including a rep-
lication of the variant identiﬁed by ENIGMA) in a sample of over 9000
elderly participants (Bis et al., 2012).
There has been heated debate as towhether the penetrance of genet-
ic variants is higher for these neuroimaging-derived endophenotypes
than for complex, binary diagnostic outcomes (see Fig. 1; Franke et al.,
2016). If effect sizes are greater for common variants that affect some
key imaging traits, or if less of the genome explainsmore of the variance,
imaging genomics may offer a more efﬁcient method to discover genes
involved in different neurological or psychiatric illnesses than tradition-
al case–control association studies (Mier andMeyer-Lindenberg, 2009).
Indeed, as imaging genomics collaborations, such as the ENIGMA con-
sortium, continue to grow their sample sizes to over 30,000 participants,
the discovery rate for novel genetic loci associated with important brain
regions continues to increase (Hibar et al., 2015). The effects of loci asso-
ciated with brain measures are actively being explored in many psychi-
atric and neurologic illnesses (Meyer-Lindenberg, 2010; Roussotte et al.,
529S. Alhusaini et al. / NeuroImage: Clinical 12 (2016) 526–5342014), and in animal models (Ashbrook et al., 2014). Imaging genomics
in future may offer a new and powerful method to improve our under-
standingof epilepsy and its elusive genetic underpinnings. So far, several
QMRI-based studies have attempted to validate an epilepsy-relatedTable 1
A summary of QMRI studies that investigated ﬁrst-degree relatives of people with epilepsy (19
First author Year Sample Method Findings
Focal epilepsies
Alhusaini 2016 - 50 patients with
MTLE + HS
- 50 asymptomatic
siblings of patients
- 40 healthy
controls
Surface-based morphometry
(FreeSurfer) was applied to
characterize temporal
cortex morphology features
Altered
identiﬁe
anterio-
entorhin
tempora
morpho
asympto
morpho
loss that
in cereb
Whelan 2015a - 25 patients with
sporadic MRI--
negative MTLE pa-
tients
- 25 asymptomatic
siblings
- 60 controls
DTI whole-brain voxel-wise
statistics and deterministic
tractography
Signiﬁca
callosum
fasciculi
fasciculi
(CST) w
increase
their asy
SLF and
Suemitsu 2014 - 26 patients with
FMTLE
- 9 asymptomatic
relatives
- 40 controls
The degree of hippocampal
T2 relaxometry changes was
examined
In a cros
relaxom
interme
asympto
A longitu
revealed
of the ip
patients
Tsai 2013 - 32 asymptomatic
ﬁrst-degree rela-
tives of MTLE +
HS patients
- 32 controls
Manual hippocampal
volumetry
Mean hi
asympto
Addition
more as
greater i
family h
Alhusaini 2013 - 101 ‘sporadic’
MTLE patients
- 83 asymptomatic
siblings of patients
- 86 controls
FreeSurfer (an automated
segmentation tool)
Volume
hippoca
noted in
MRI-neg
were no
of MTLE
Scanlon 2013 - 28 MTLE + HS pa-
tients
- 12 asymptomatic
siblings of patients
- 28 controls
FreeSurfer A signiﬁ
common
Kobayashi 2002 - 52 asymptomatic
individuals from
11 families with
FMTLE
- 30 controls
Manual hippocampal
volumetry
Hippoca
ﬁrst-deg
of T1- an
addition
18 indiv
Jackson 1998 - three monozygous
(MZ) twin pairs
discordant for
MTLE + HS
- 30 controls
Manual hippocampal
volumetry
HS was
using vi
criteria
Fernández 1998 - 23 members of
two families of
patients with
MTLE + HS (13
had experienced
FS)
- 23 controls
Manual hippocampal
volumetry: the right/left
ratios of hippocampal
volumes (RHV)
All subje
not deve
asympto
but norm
Genetic generalized epilepsies (GGEs)
Wandschneider 2014 - 15 asymptomatic
siblings of JME pa-
tients
- 20 controls
fMRI was applied to record
brain activation during a
working memory paradigm
The asym
abnorm
supplem
increasin
task-rela
motor aneuroimaging endophenotype by exploring potential co-segregation of
neuroanatomical and functional alterations in people with epilepsy
and their asymptomatic ﬁrst-degree relatives. The next section offers a
comprehensive review of these investigations.98–2016).
Comment
temporal cortex morphology was
d in patients ipsilaterally within the
medial temporal regions, including the
al cortex, parahippocampal gyrus, and
l pole. Subtle but similar pattern of
logy change was also noted in the
matic siblings. This localized
logy alteration was related to volume
appeared driven by shared contraction
ral cortex surface area.
MTLE + HS patients and their
asymptomatic siblings share a common
pattern of temporal cortex morphologic
alteration.
nt FA reductions in the corpus
(CC), bilateral superior longitudinal
(SLF), bilateral inferior longitudinal
(ILF), and ipsilateral corticospinal tract
ere noted in patients only. MD
s were observed in MTLE patients and
mptomatic siblings in the ipsilateral
CST.
SLF and CST microstructural alterations in
patients with MRI-negative MTLE may
partly be inﬂuenced by genetic factors.
s-sectional design, elevated T2
etry was identiﬁed in patients and
diate values were noted in the
matic relatives compared to controls.
dinal follow up over a mean of 4.4 year
signiﬁcant increase in T2 relaxometry
silateral hippocampus exclusively in
. With recurrent seizures
Genetic factors may be involved in the
development of some mild hippocampal
abnormalities in FMTLE.
ppocampal volume was smaller in the
matic relatives compared to controls.
ally, the asymptomatic relatives had
ymmetric hippocampi. This effect was
n relatives of probands with a positive
istory of epilepsy.
Small asymmetric hippocampi in healthy
relatives of patients could represent a
familial developmental variant that may
predispose to the formation of MTLE + HS.
deﬁcits across the ipsilateral
mpus, amygdala and thalamus were
MTLE + HS patients but not
ative MTLE. These volume deﬁcits
t present in the asymptomatic siblings
+ HS patients.
Volume deﬁcits for many subcortical
structures in ‘sporadic’MTLE + HS are
largely driven by acquired factors.
cant volume deﬁcit in cerebral WMwas
to patient and their siblings.
Cerebral WM volume deﬁcit is common to
MTLE + HS patients and their siblings.
mpal atrophy was identiﬁed in 18 of 52
ree relatives of patients. Visual analysis
d T2-weighted images showed
al classic MRI signs of HS in 14 of these
iduals
HS in FMTLE is inﬂuenced by a signiﬁcant
genetic predisposition.
not identiﬁed in the unaffected twin
sual, volumetric, and T2 relaxometry
The absence of HS in the unaffected twin is
arguing against a strictly genetic hypothesis
for HS.
cts with febrile convulsions who did
lop epilepsy and six clinically
matic relatives showed asymmetric HV
al hippocampal signal intensity.
A subtle, pre-existing hippocampal
alteration may predispose to febrile
convulsions and contribute to the
development of subsequent HS.
ptomatic siblings of patients showed
al primary motor cortex and
entary motor area co-activation with
g cognitive load, as well as increased
ted functional connectivity between
nd prefrontal cognitive networks
Altered motor system activation and
functional connectivity may represents a
potential familial trait for JME
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Over the last two decades, epilepsy-related EEG and brain QMRI
traits have been evaluated as possible endophenotypes. Studies that ex-
amined the endophenotypic potential of QMRI traits in epilepsy are
summarized in Table 1.
5.1. QMRI traits as endophenotypes for focal epilepsies
Most studies exploring potential neuroimaging endophenotypes for
epilepsy focus on focal syndromes, primarily MTLE. MTLE is the most
prevalent form of medically intractable focal epilepsy. The most com-
mon pathology underlying MTLE is hippocampal sclerosis (HS), which
is characterized histologically by cellular loss and synaptic reorganiza-
tion within hippocampal subregions (Wieser and ILAE Commission on
Neurosurgery of epilepsy, 2004). HS can be detected using MRI in up
to 70% of MTLE patients through the identiﬁcation of hippocampal atro-
phy and signal abnormalities (Blümcke et al., 2013). The underlying eti-
ology of HS remains a subject of debate, although the latest evidence
indicates an interaction of several polygenic and environmental factors
(Lewis et al., 2014).
The heritability of HS has been examined by a number of investiga-
tors. The majority of these investigations were conducted on relatively
small sample sizes. Fernández et al. (1998) investigated 23 familymem-
bers of patientswithMTLE associatedwith HS (MTLE+HS) and report-
ed a signiﬁcant hippocampal asymmetry in the asymptomatic family
members who had experienced febrile seizures (FS) during childhood
(Fernández et al., 1998). Hippocampal asymmetry was also identiﬁed
in up to 50% of those family members who had never experienced FS.
A follow up study by Kobayashi et al. (2002) examined 52 asymptomat-
ic members of 11 families of patients with MTLE + HS. Signiﬁcant hip-
pocampal atrophy was identiﬁed in up to 34% of the asymptomatic
relatives (Kobayashi et al., 2002). In addition, visual inspection of the
T1- and T2-weighted images revealed classicMRI features of HS, includ-
ing abnormal T2 signal abnormalities and altered internal structure of
the hippocampus, in most of these relatives (Kobayashi et al., 2002).
These two studies were complemented by a more recent investigation
that explored HV in 32 asymptomatic ﬁrst-degree relatives of
MTLE+HSpatients (Tsai et al., 2013). Here, the authors reported signif-
icantly reducedHV in the asymptomatic relatives of patientswhen com-
pared to healthy controls (Tsai et al., 2013). This trend appeared
stronger in the relatives of patients with a family history of epilepsy
(see Fig. 2). Contrastingly, an independent investigation of MTLE + HS
patients who reported no family history of seizures (i.e., sporadic
cases) and their asymptomatic siblings (n = 50 discordant sibling
pairs) reported no signiﬁcant HV deﬁcits in the asymptomatic siblingsFig. 2. The distribution of hippocampal volume in the asymptomatic relatives of MTLE + HS pa
(red) had smaller hippocampal volume relative to the healthy controls (blue). The same data is
90% conﬁdence ellipse of the relatives of probands with a positive family history (FH) displaye
(Neurology, 2013)].(Alhusaini et al., 2013). A trend of volume reduction was, however,
noted in the hippocampus ipsilateral to the side of HS (Alhusaini et al.,
2013). The authors attributed these ﬁndings to the possibly limited sen-
sitivity of their automated segmentation technique relative to standard-
ized manual tracing methods and to the small sample size (Alhusaini
et al., 2016). Further evidence for the role of genetic contributions to-
wards hippocampal structural abnormalities was recently illustrated
by a study that applied T2-relaxometry to indirectly quantify the degree
of hippocampal structural alteration in patients with MTLE + HS and
their asymptomatic relatives (Suemitsu et al., 2014). The investigators
reported increased hippocampal T2-relaxometry signal in patients rela-
tive to controls, and an intermediate relaxometry value for the asymp-
tomatic relatives of patients (Suemitsu et al., 2014). Despite some
inconsistencies, theﬁndings of the above studies suggest a familial com-
ponent to hippocampal structural alterations inMTLE+HS, particularly
in patients with a strong family history for seizures.
Over the last two decades, collective neuroimaging evidence has
pointed towidespread structural alteration inMTLE+HS, extending be-
yond the hippocampus and mesial temporal lobe. Regional atrophy has
been described in several subcortical GM structures (Bernasconi et al.,
2003; McDonald et al., 2008), the ipsilateral temporal cortex (Moran
et al., 2001; Alhusaini et al., 2012b), and several fronto-limbic cortical re-
gions (Keller and Roberts, 2008; Mueller et al., 2009; Voets et al., 2011),
suggesting an alteration in interconnected brain regions and localized
brain networks (Bernhardt et al., 2013). The endophenotypic quality of
these extra-hippocampal neuroanatomical alterations in MTLE has
been explored by two separate studies (Alhusaini et al., 2013, 2016).
Using an automated segmentation method, the volume of ﬁve subcorti-
cal structures (amygdala, thalamus, caudate, putamen and globus
pallidus) was compared between asymptomatic siblings of MTLE + HS
patients and healthy controls (Alhusaini et al., 2013). No signiﬁcant
group differenceswere noted in the volume of any of theﬁve subcortical
structures, although a trend of reduced amygdalar volumewas reported
in the siblings of patients (Alhusaini et al., 2013). In a separate investiga-
tion, temporal cortexmorphologywas examined inMTLE+HS patients
and their siblings (Alhusaini et al., 2016). A contraction in surface area
was noted within the anterio-medial regions of the temporal cortex in
patients and their asymptomatic siblings (Alhusaini et al., 2016). Inter-
estingly, this altered surface area pattern was observed ipsilateral to
the side of HS of the affected siblings, suggesting the possibility of a com-
mon driving process. WM tract integrity was also investigated in pa-
tients with MRI-negative MTLE and their siblings using diffusion-
tensor imaging (DTI; Whelan et al., 2015a). Subtle microstructural
alterations of the superior longitudinal fasciculus were reported in the
asymptomatic siblings in a pattern similar to that displayed by patients
(see Fig. 3), highlighting the endophenotypic potential of WMtients and healthy controls is displayed (Tsai et al., 2013). (A): The symptomatic relatives
displayed in (B), with 90% conﬁdence ellipse of the controls displayed in the blue oval, and
d in the red oval. [Image is reproduced with permission fromWolters Kluwer Health, Inc.
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replication studies to validate the aboveﬁndings are yet to be conducted,
these results provide preliminary evidence for the eligibility of QMRI
neuroanatomical traits as endophenotypes for MTLE.
5.2. QMRI traits as endophenotypes for genetic generalized epilepsies
GGEs (previously known as primary generalized epilepsies or idio-
pathic generalized epilepsies) refer to a group of characteristic epilepsy
syndromeswith a knownor presumedgenetic defect in the absence of ei-
ther structural brain abnormality or an acquired pathology (Berg et al.,
2010; Gallentine and Mikati, 2012). Although the biological basis of the
majorityGGE syndromes remains unknown, evidence fromEEGandneu-
roimaging studies suggests a link to disruptions in thalamo-frontal brain
networks (Duncan, 2005). Juvenile myoclonic epilepsy (JME) is the most
common of the GGEs; accounting for 5% to 10% of all epilepsies. Although
visual inspection of routine brain MRI in JME patients reveals no visible
abnormality, QMRI studies have detected several subtle neuroanatomical
abnormalities, such as thalamic volume loss and increased mesio-frontal
and frontobasal GM concentration (Woermann et al., 1999; Betting et al.,Fig. 3.Whole-brain, voxel-wise comparisons of brain diffusion tensor imaging (DTI) measures,
MRI-negative mesial temporal lobe epilepsy (MTLE), their asymptomatic siblings and healthy
reduced FA (illustrated in red) in voxel clusters encompassing the corpus callosum, ipsilat
longitudinal fasciculi (SLF), and bilateral inferior longitudinal fasciculi (ILF) compared to hea
compared to the same controls. Compared to controls, MTLE patients exhibited patterns of inc
patterns of increased MD along the ipsilateral SLF and ipsilateral CST (illustrated in yellow) w
Wiley and Sons (Epilepsia, 2015)].2006; Alhusaini et al., 2013). These observations have been supported by
positron emission tomography (PET) and proton magnetic resonance
spectroscopy studies (Lin et al., 2009), indicating that the underlying
mechanisms in JME may relate to aberrant frontothalamic structure
(Duncan, 2005). Nonetheless, a clear set of GGE-speciﬁc neuroanatomical
markers has not yet been fully characterized, and the endophenotypic
property of frontothalamic alterations remains to be determined.
Recently, Wandschneider et al. (2014) applied functional MRI to ex-
plore the endophenotypic theory in JME (Wandschneider et al., 2014).
In this study, brain activation during a working memory task was com-
pared between15 asymptomatic siblings of JME patients and 20 healthy
controls. Abnormal primary motor cortex and supplementary motor
area co-activation was noted in the asymptomatic siblings when com-
pared to controls. This was consistent with a report of similar abnormal
pattern of activation in JME patients using the same memory task
(Vollmar et al., 2011), suggesting that abnormal motor cortex connec-
tivity may represent a familial trait in JME. Although the speciﬁcity of
this trait to JME was questioned (Berkovic and Jackson, 2014), the
study was the ﬁrst to explore the applicability of QMRI to identify
endophenotypes in GGEs.including fractional anisotropy (FA) andmean diffusivity (MD), in a group of patients with
controls are shown (Whelan et al., 2015a). Patients with MTLE demonstrated patterns of
eral anterior thalamic radiation, ipsilateral corticospinal tract (CST), bilateral superior
lthy controls. The asymptomatic siblings did not show signiﬁcant FA compromise when
reased MD across the SLF bilaterally and the CST ipsilaterally (illustrated in blue). Similar
ere noted in the asymptomatic siblings. [Image is reproduced with permission from John
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The ﬁeld of imaging genomics has expanded signiﬁcantly over the
last decade. Its application in epilepsy holdsmuchpromise. Characteriz-
ing epilepsy-relevant neuroimaging endophenotypes represents the
ﬁrst step towards expediting this research ﬁeld. Unraveling the genetic
determinants of relevant neuroimaging traits will undoubtedly provide
valuable insight into theunderlyingmechanisms of the commonepilep-
sy syndromes.
In Section 5, we discussed a number of neuroimaging traits that may
fulﬁll the criteria of an endophenotype for two epilepsy syndromes,
MTLE and JME. Additional studies using larger sample sizeswill help val-
idate these traits as intermediate phenotypes for future geneticmapping
efforts. At present, HV in MTLE + HS appears to be the most promising
neuroimaging endophenotype in epilepsy. Mapping the genetic deter-
minants of HV in patients with MTLE + HS could unravel novel genetic
variants linked to the pathogenesis of MTLE+HS. It is important to rec-
ognize, however, that the eligibility of HV as an endophenotype for
MTLE+HScould be compromised by the impact ofmany signiﬁcant en-
vironmental factors (Alhusaini et al., 2012a). Early brain insults (such as
atypical FS, CNS infection, and signiﬁcant head injury) are known risk
factors for hippocampal damage and MTLE + HS (Scott et al., 2003;
Lewis et al., 2014). In addition, the impact of epilepsy chronicity on hip-
pocampal structure, including the effect of recurrent seizure activity,
needs consideration (Fuerst et al., 2003). Nevertheless, some early in-
sults, such as FS, could be genetically mediated and exploring their role
in epilepsy predisposition is crucial (Feenstra et al., 2014). The potential
limitation of environmental factors could be addressed by mapping HV
genetic determinants in healthy human populations to indirectly inform
on the genetic underpinnings of HV loss in MTLE + HS. An example of
this approach is currently underway through collaboration between
the ILAE and ENIGMA consortium (Whelan et al., 2015b).
Another important point to consider is the speciﬁcity of HV as an im-
aging trait for MTLE + HS. Hippocampal atrophy is associated with
many other brain-related conditions such as AD (Jack et al., 1998). Fur-
ther, reduced HV has been described in patients with schizophrenia
(Wright et al., 2000), depression (Koolschijn et al., 2009), and post-
traumatic stress disorder (Karl et al., 2006). Identifying genetic variants
that inﬂuence HV is less likely to elucidate susceptibility variants unique
to each brain condition, but may provide an opportunity to characterize
biological pathways shared by such complex brain-related disorders,
which themselves may be co-morbid. Shared underlying mechanisms
between epilepsy and other neurologic and psychiatric disorders, in-
cluding genetic processes, have been suggested by the observation
that epileptic seizures form part of the wide phenotype of some brain-
related conditions, such as autism spectrumdisorder (Blackmon, 2015).
Over the last two decades, the search for neuroimaging
endophenotypes has expanded. In addition to volumetric and functional
QMRI, several research groups have examined cerebral cortex mor-
phometry (e.g., cortical thickness and folding patterns), subcortical
shape, and high-angular resolution DTI parameters as alternative ap-
proaches to characterize sensitive neuroimaging QTs. Many of these ad-
vanced techniques have been applied in epilepsy populations (Free
et al., 1996; Sisodiya and Free, 1997; Mueller et al., 2009; Voets et al.,
2011; Labate et al., 2015), but they have yet to be utilized to validate
suitable endophenotypes. Alternative subclinical traits have also
shown promising results. For example, the photoparoxysmal response
(PPR) - an abnormal EEG trait that is provoked by intermittent photic
stimulation and marked by diffuse paroxysmal discharges recorded as
spike-wave complexes - is observed in up to 15% of GGEs and 40% of
JME patients (Wolf and Goosses, 1986; Guerrini and Genton, 2004;
Trenité, 2006). PPR has shown 100% concordance in monozygotic
twins and a sibling recurrence risk of 20–30% (Doose and Waltz, 1993;
Tauer et al., 2005). Interestingly, associations between PPR and candi-
date genes, including NEDD4-22, TRPC4 and BRD2, have previously
been established (Lorenz et al., 2006; Dibbens et al., 2007; von Spiczaket al., 2010). Although a PPR gene has yet to be identiﬁed for common
forms of epilepsy (Koeleman et al., 2013), this EEG trait is associated
with de novo mutations in the CHD2 gene, which also confer risk for
rare forms of photosensitive epilepsy (Thomas et al., 2015; Galizia
et al., 2015). EEG-based topological network measures have also
shown a potential genetic basis in epilepsy populations. For example,
GGE patients and their asymptomatic relatives show greater mean de-
gree (mean number of connections between nodes in a brain network)
and degree distribution variance (probability distribution of connections
between nodes in a brain network) compared to healthy controls in the
6–9 Hz band, suggesting possible co-segregation of abnormal brain net-
work properties (Chowdhury et al., 2014a). Finally, evidence of a paral-
lel proﬁle of cognitive deﬁcits has been reported in GGE patients and
their ﬁrst-degree relatives, with both groups showing impairments in
nonverbal reasoning, verbal generativity, working memory and
sustained attention (Chowdhury et al., 2014b).
As international collaborations such as the ILAE Consortium on Com-
plex Epilepsies (http://www.ilae.org/Commission/class/consortium.cfm)
continue to boost power to detect common genetic variants associated
with common epilepsy syndromes, the traditional genome-wide genetic
mapping approach may remain constrained by phenotypic heterogene-
ity, replicability issues and inevitable debates concerning missing herita-
bility. This review discusses promising alternatives to the traditional
clinical phenotypes historically employed by GWAS. Collective evidence
from QMRI, EEG, and neuropsychology studies indicates the potential
utility of several subclinical QTs as sensitive endophenotypes for particu-
lar epilepsy syndromes. Amongst these traits, QMRI-derived measures
may serve as the most accessible and relevant endophenotypes for epi-
lepsy. As the ﬁelds of neuroimaging and human genetics continue to ad-
vance, it is our hope that these intermediate phenotypes continue to be
explored and, eventually, employed as useful tools in our continuing in-
vestigation of this highly complex neurological disorder.Acknowledgments
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